Hexembio

About Hexembio

Hexembio is a biotechnology company focusing on aging and hematopoietic stem cell rejuvenation through advanced stem cell therapies. The company develops regenerative approaches aimed at extending healthy lifespan by rejuvenating blood-forming stem cells and improving immune function, using early developmental states and synthetic niche strategies. It operates from New York City with researchers and leadership spanning the United States, including notable team members with expertise in biology, medicine, and AI-driven insights.